Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3447)
All Articles published online
|
Mar 7, 2006 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Csepregi A, Röcken C, Treiber G, Malfertheiner P. Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol 2006; 12(9): 1362-1366 [PMID: 16552802 DOI: 10.3748/wjg.v12.i9.1362] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i9/1362.htm |
| Number | Citing Articles |
| 1 |
Albert J Czaja. Clinical Features, Differential Diagnosis and Treatment of Autoimmune Hepatitis in the Elderly. Drugs & Aging 2008; 25(3): 219 doi: 10.2165/00002512-200825030-00005
|
| 2 |
Michael P. Manns, Elmar Jaeckel, Richard Taubert. Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right Patient. Clinical Gastroenterology and Hepatology 2018; 16(2): 186 doi: 10.1016/j.cgh.2017.11.003
|
| 3 |
Albert J. Czaja, Michael P. Manns. Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis. Gastroenterology 2010; 139(1): 58 doi: 10.1053/j.gastro.2010.04.053
|
| 4 |
Ignasi Olivas, Marina Cobreros, María-Carlota Londoño, Álvaro Díaz-González. Budesonide in the first line treatment of patients with autoimmune hepatitis. Gastroenterología y Hepatología 2022; 45(7): 561 doi: 10.1016/j.gastrohep.2021.11.012
|
| 5 |
Marina G Silveira, Keith D Lindor. Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis. Expert Opinion on Pharmacotherapy 2014; 15(3): 365 doi: 10.1517/14656566.2014.873404
|
| 6 |
Khurram Bari, Shimul A. Shah, Tiffany E. Kaiser, Robert M. Cohen, Nadeem Anwar, David Kleesattel, Kenneth E. Sherman. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial. Liver Transplantation 2020; 26(11): 1430 doi: 10.1002/lt.25837
|
| 7 |
Marlyn J Mayo. Management of autoimmune hepatitis. Current Opinion in Gastroenterology 2011; 27(3): 224 doi: 10.1097/MOG.0b013e3283457ce0
|
| 8 |
Rima Fawaz, Maureen M. Jonas. Pediatric Gastrointestinal and Liver Disease. 2011; : 811 doi: 10.1016/B978-1-4377-0774-8.10075-2
|
| 9 |
Albert J. Czaja. Advances in the Current Treatment of Autoimmune Hepatitis. Digestive Diseases and Sciences 2012; 57(8): 1996 doi: 10.1007/s10620-012-2151-2
|
| 10 |
A. D. YEOMAN, M. S. LONGHI, M. A. HENEGHAN. Review article: the modern management of autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 2010; 31(8): 771 doi: 10.1111/j.1365-2036.2010.04241.x
|
| 11 |
Michael A Heneghan, Andrew D Yeoman, Sumita Verma, Alastair D Smith, Maria Serena Longhi. Autoimmune hepatitis. The Lancet 2013; 382(9902): 1433 doi: 10.1016/S0140-6736(12)62163-1
|
| 12 |
|
| 13 |
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 2009; 51(2): 237 doi: 10.1016/j.jhep.2009.04.009
|
| 14 |
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata, Shiv Kumar Sarin. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 2021; 15(2): 223 doi: 10.1007/s12072-021-10170-1
|
| 15 |
Kenneth R Snider, Teresa G Potter. Budesonide for the Treatment of Autoimmune Hepatitis. Annals of Pharmacotherapy 2011; 45(9): 1144 doi: 10.1345/aph.1Q244
|
| 16 |
Saumya Pathak, Deepak Kamat. Autoimmune Hepatitis in Children. Pediatric Annals 2018; 47(2) doi: 10.3928/19382359-20180126-01
|
| 17 |
Aldo J Montano Loza, Albert J Czaja. Current therapy for autoimmune hepatitis. Nature Clinical Practice Gastroenterology & Hepatology 2007; 4(4): 202 doi: 10.1038/ncpgasthep0768
|
| 18 |
V. Selvarajah, A. J. Montano‐Loza, A. J. Czaja. Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs. Alimentary Pharmacology & Therapeutics 2012; 36(8): 691 doi: 10.1111/apt.12042
|
| 19 |
Claudia Della Corte, Antonella Mosca, Andrea Vania, Arianna Alterio, Anna Alisi, Valerio Nobili. Pediatric liver diseases: current challenges and future perspectives. Expert Review of Gastroenterology & Hepatology 2016; 10(2): 255 doi: 10.1586/17474124.2016.1129274
|
| 20 |
Edward L Krawitt. Clinical features and management of autoimmune hepatitis. World Journal of Gastroenterology 2008; 14(21): 3301-3305 doi: 10.3748/wjg.14.3301
|
| 21 |
Ignasi Olivas, Marina Cobreros, María-Carlota Londoño, Álvaro Díaz-González. Budesonide in the first line treatment of patients with autoimmune hepatitis. Gastroenterología y Hepatología (English Edition) 2022; 45(7): 561 doi: 10.1016/j.gastre.2021.11.003
|
| 22 |
Cumali Efe, Ersan Ozaslan, Taylan Kav, Tugrul Purnak, Ali Shorbagi, Ozgür Ozkayar, Alexandra Heurgue Berlot, Cenk Sökmensuer, Paolo Muratori. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome. Autoimmunity Reviews 2012; 11(5): 330 doi: 10.1016/j.autrev.2011.09.006
|
| 23 |
Roger D. Soloway, Alexander T. Hewlett. The medical treatment for autoimmune hepatitis through corticosteroid to new immunosuppressive agents: A concise review. Annals of Hepatology 2007; 6(4): 204 doi: 10.1016/S1665-2681(19)31899-X
|
| 24 |
Aldo J. Montano‐Loza, Herschel A. Carpenter, Albert J. Czaja. Consequences of treatment withdrawal in type 1 autoimmune hepatitis. Liver International 2007; 27(4): 507 doi: 10.1111/j.1478-3231.2007.01444.x
|
| 25 |
Yan Zhang, Jie Lu, Weiqi Dai, Fan Wang, Miao Shen, Jing Yang, Rong Zhu, Huawei Zhang, Kan Chen, Ping Cheng, Lei He, Chengfen Wang, Ling Xu, Yingqun Zhou, Chuanyong Guo. Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/490731
|
| 26 |
Lise Lotte Gluud, Eva Efsen Dahl, Ahmed Al-Rifai, Martin Prince. Medical treatments for autoimmune hepatitis. Cochrane Database of Systematic Reviews 2009; doi: 10.1002/14651858.CD004543.pub2
|
| 27 |
Claudia Della Corte, Maria Rita Sartorelli, Carmen Donatella Sindoni, Elia Girolami, Luigi Giovannelli, Donatella Comparcola, Valerio Nobili. Autoimmune hepatitis in children. European Journal of Gastroenterology & Hepatology 2012; 24(7): 739 doi: 10.1097/MEG.0b013e328353750c
|
| 28 |
Atsushi Tanaka. Treatment of autoimmune hepatitis -approach to the establishment of evidence-based guidelines. Kanzo 2006; 47(5): 233 doi: 10.2957/kanzo.47.233
|
| 29 |
Kareem Sassi, Jose M. Nieto, Sammy Saab. Transplantation of the Liver. 2015; : 174 doi: 10.1016/B978-1-4557-0268-8.00015-4
|
| 30 |
Moritz Peiseler, Tina Liebscher, Marcial Sebode, Roman Zenouzi, Johannes Hartl, Hanno Ehlken, Nadine Pannicke, Christina Weiler-Normann, Ansgar W. Lohse, Christoph Schramm. Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis. Clinical Gastroenterology and Hepatology 2018; 16(2): 260 doi: 10.1016/j.cgh.2016.12.040
|
| 31 |
Syed Rizvi, Samer Gawrieh. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management. Drugs & Aging 2018; 35(7): 589 doi: 10.1007/s40266-018-0556-0
|
| 32 |
EASL Clinical Practice Guidelines: Autoimmune hepatitis. Journal of Hepatology 2015; 63(4): 971 doi: 10.1016/j.jhep.2015.06.030
|
| 33 |
Antal Csepregi, Peter Malfertheiner. Do we need alternative treatment options for autoimmune hepatitis?. Current Gastroenterology Reports 2006; 8(3): 177 doi: 10.1007/s11894-006-0069-6
|
| 34 |
Rima Fawaz, Maureen M. Jonas. Pediatric Gastrointestinal and Liver Disease. 2021; : 819 doi: 10.1016/B978-0-323-67293-1.00075-X
|
| 35 |
Rubén Peña-Vélez, Enory Almanza-Miranda. Hepatitis autoinmune en la edad pediátrica. Boletín Médico del Hospital Infantil de México 2017; 74(5): 324 doi: 10.1016/j.bmhimx.2017.05.004
|
| 36 |
A. J. Czaja. Review article: the management of autoimmune hepatitis beyond consensus guidelines. Alimentary Pharmacology & Therapeutics 2013; 38(4): 343 doi: 10.1111/apt.12381
|
| 37 |
Walter EB Sipe, Philip Rosenthal. Autoimmune hepatitis in children: diagnosis, pathology and treatment. Expert Review of Clinical Immunology 2007; 3(2): 159 doi: 10.1586/1744666X.3.2.159
|
| 38 |
Natanie J. Anilovich. Oral budesonide is an effective alternative to prednisone for treatment of autoimmune hepatitis. Clinical Research In Practice: The Journal of Team Hippocrates 2021; 7(2) doi: 10.22237/crp/1622160960
|
| 39 |
Tanima Bose. Bitter correlationship between autoimmune hepatitis and smoking. Medical Hypotheses 2015; 84(2): 118 doi: 10.1016/j.mehy.2014.12.006
|
| 40 |
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World Journal of Gastroenterology 2017; 23(33): 6030-6048 doi: 10.3748/wjg.v23.i33.6030
|
| 41 |
|
| 42 |
Nora Cazzagon, Olivier Chazouillères. Liver Immunology. 2020; : 375 doi: 10.1007/978-3-030-51709-0_24
|
| 43 |
P. J. Trivedi, G. M. Hirschfield. Review article: overlap syndromes and autoimmune liver disease. Alimentary Pharmacology & Therapeutics 2012; 36(6): 517 doi: 10.1111/j.1365-2036.2012.05223.x
|
| 44 |
T. Zvyagintseva, A. Chernobay. Autoimmune hepatitis. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2016; 2016(1): 33 doi: 10.15407/internalmed2016.01.033
|
| 45 |
David C. Wolf, Lizza Bojito, Marcelo Facciuto, Edward Lebovics. Mycophenolate Mofetil for Autoimmune Hepatitis: A Single Practice Experience. Digestive Diseases and Sciences 2009; 54(11): 2519 doi: 10.1007/s10620-008-0632-0
|
| 46 |
Dinesh Jothimani, Matthew E Cramp, Jonathon D Mitchell, Tim J S Cross. Treatment of autoimmune hepatitis: A review of current and evolving therapies. Journal of Gastroenterology and Hepatology 2011; 26(4): 619 doi: 10.1111/j.1440-1746.2010.06579.x
|
| 47 |
Albert J Czaja. Drug choices in autoimmune hepatitis: Part A – steroids. Expert Review of Gastroenterology & Hepatology 2012; 6(5): 603 doi: 10.1586/egh.12.40
|
| 48 |
Luigi Muratori, Paolo Muratori, Alessandro Granito, Giorgios Pappas, Fabio Cassani, Marco Lenzi. Current topics in autoimmune hepatitis. Digestive and Liver Disease 2010; 42(11): 757 doi: 10.1016/j.dld.2010.05.019
|
| 49 |
Christian Rust, Ulrich Beuers. Overlap syndromes among autoimmune liver diseases. World Journal of Gastroenterology 2008; 14(21): 3368-3373 doi: 10.3748/wjg.14.3368
|